GE HealthCare Q4 EPS Beats By 0.7% With $5.7B Revenue
GE HealthCare Technologies posted fourth-quarter 2025 adjusted earnings per share of $1.44, beating the consensus estimate by 0.7%, and reported $5.7 billion in revenues, exceeding projections by 1.9%. The company carries a Zacks Rank #2 (Buy) with an estimated long-term earnings growth rate of 9.1% versus the industry’s 13.4%.
1. Q4 2025 Financial Performance
GE HealthCare delivered adjusted earnings per share of $1.44 in the fourth quarter of 2025, surpassing the consensus estimate by 0.7%. Revenue reached $5.7 billion, ahead of analyst projections by 1.9%, driven by strength across its imaging and diagnostics equipment segments.
2. Growth Outlook and Analyst Ranking
The company holds a Zacks Rank #2 (Buy) and is projected to achieve a 9.1% compound annual earnings growth rate, compared with a 13.4% industry average, reflecting solid but moderately paced expansion backed by ongoing investments in product innovation and service offerings.